tyrosine has been researched along with oxidopamine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.50) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 12 (50.00) | 29.6817 |
| 2010's | 5 (20.83) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Girault, JA; Hervé, D; Robel, L; Siciliano, JC | 1 |
| Hossain, MA; Masserano, JM; Weiner, N | 1 |
| Acworth, IN; During, MJ; Wurtman, RJ | 1 |
| Milner, JD; Reinstein, DK; Wurtman, RJ | 1 |
| Fung, YK; Uretsky, NJ | 1 |
| Carey, RJ; Dai, H; Huston, JP; Pinheiro-Carrera, M; Schwarting, RK; Tomaz, C | 1 |
| Girault, JA; Hervé, D; Huganir, RL; Lau, LF; Menegoz, M | 1 |
| Jenner, P; Rose, S; Treseder, SA | 1 |
| Bauer, JA; Mihm, MJ; Schanbacher, BL; Uretsky, NJ; Wallace, BL; Wallace, LJ | 1 |
| Boveris, AD; Cadenas, E; Poderoso, JJ; Riobó, NA; Schöpfer, FJ | 1 |
| Cai, G; Friedman, E; Torres, C; Zhen, X | 1 |
| Schmidt, WJ; Srinivasan, J | 2 |
| Cho, JW; Choi, EJ; Choi, WS; Eom, DS; Han, BH; Han, BS; Kim, WK; Markelonis, GJ; Oh, TH; Oh, YJ | 1 |
| Bezard, E; Guo, S; Zhao, B | 1 |
| Akaike, A; Hayashi, K; Inden, M; Kitamura, Y; Kondo, J; Nishimura, K; Shimohama, S; Sugimoto, H; Takata, K; Taniguchi, T; Tsuchiya, D; Yanagida, T; Yanagisawa, D | 1 |
| Chan, P; Wang, L; Xu, S; Xu, X | 1 |
| Ugrumov, MV | 1 |
| Dayton, RD; Klein, RL; Sunderland, JJ; Tainter, KH; Terry, TL; Vascoe, C | 1 |
| Chen, J; Jiang, L; Li, X; Sun, X; Tao, L; Tian, J; Zhang, L; Zhang, X | 1 |
| Alonso-Gil, S; Chavarría, C; Gil, C; Morales Garcia, JA; Pérez, C; Perez, DI; Pérez-Castillo, A; Porcal, W; Souza, JM | 1 |
| Anantharam, V; Gordon, R; Harischandra, DS; Jin, H; Kanthasamy, A; Kanthasamy, AG; Kanthasamy, K; Lawana, V; Luo, J; Neal, M; Panicker, N; Saminathan, H; Sarkar, S | 1 |
| Asensio, MJ; García-Sanz, P; Herranz, AS; Moratalla, R; Solís, O | 1 |
| Bahri, MA; Becker, G; Garraux, G; Hustadt, F; Lemaire, C; Luxen, A; Michel, A; Plenevaux, A | 1 |
1 review(s) available for tyrosine and oxidopamine
| Article | Year |
|---|---|
[Synthesis of monoamines by non-monoaminergic neurons: illusion or reality?].
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Brain; Corpus Striatum; Dopamine; Humans; Hypothalamus; Levodopa; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Serotonin; Substantia Nigra; Tyrosine; Tyrosine 3-Monooxygenase | 2009 |
23 other study(ies) available for tyrosine and oxidopamine
| Article | Year |
|---|---|
Stimulation of protein-tyrosine phosphorylation in rat striatum after lesion of dopamine neurons or chronic neuroleptic treatment.
Topics: Animals; Antipsychotic Agents; Basal Ganglia; Corpus Striatum; Dopamine; Male; Molecular Weight; Motor Activity; Nerve Tissue Proteins; Oxidopamine; Phosphoproteins; Phosphotyrosine; Protein-Tyrosine Kinases; Rats; Rats, Inbred Strains; Substantia Nigra; Tyrosine | 1992 |
Comparative effects of electroconvulsive shock and haloperidol on in vivo tyrosine hydroxylation and tetrahydrobiopterin in the brain of rats with 6-hydroxydopamine lesions.
Topics: Animals; Biopterins; Brain; Electroshock; Haloperidol; Hydroxylation; Male; Neurons; Oxidopamine; Rats; Rats, Sprague-Dawley; Stress, Physiological; Tyrosine | 1992 |
Dopamine release in rat striatum: physiological coupling to tyrosine supply.
Topics: Animals; Corpus Striatum; Dialysis; Dopamine; Extracellular Space; Feedback; Haloperidol; Hydroxydopamines; Kinetics; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra; Tyrosine | 1989 |
Dopamine synthesis in rat striatum: mobilization of tyrosine from non-dopaminergic cells.
Topics: Animals; Corpus Striatum; Dopamine; Electric Stimulation; Hydroxydopamines; Leucine; Male; Oxidopamine; Rats; Rats, Inbred Strains; Substantia Nigra; Tyrosine | 1987 |
The importance of calcium in the amphetamine-induced stimulation of dopamine synthesis in mouse striata in vivo.
Topics: Amphetamine; Animals; Calcium; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Egtazic Acid; Hydroxydopamines; Kinetics; Mice; Motor Activity; Oxidopamine; Rotation; Tyrosine | 1982 |
L-DOPA metabolism in cortical and striatal tissues in an animal model of parkinsonism.
Topics: Animals; Dopamine; Levodopa; Male; Neostriatum; Oxidopamine; Parkinson Disease, Secondary; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques; Tyrosine | 1995 |
Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions.
Topics: Animals; Corpus Striatum; Dopamine; Functional Laterality; Immunoblotting; Male; Molecular Structure; Neurons; Oxidopamine; Phosphorylation; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine | 1995 |
The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior, Animal; Biogenic Monoamines; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Combinations; Enzyme Inhibitors; Haloperidol; Homovanillic Acid; Hydrazines; Levodopa; Male; Medial Forebrain Bundle; Oxidopamine; Rats; Rats, Wistar; Stereotyped Behavior; Tyrosine | 2001 |
Free 3-nitrotyrosine causes striatal neurodegeneration in vivo.
Topics: Animals; Cell Count; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Immunohistochemistry; Mice; Motor Activity; Neurodegenerative Diseases; Neurons; Oxidopamine; Substantia Nigra; Tyrosine; Tyrosine 3-Monooxygenase | 2001 |
The reaction of nitric oxide with 6-hydroxydopamine: implications for Parkinson's disease.
Topics: alpha-Synuclein; Animals; Cattle; Nerve Tissue Proteins; Nitric Oxide; Oxidation-Reduction; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Peroxynitrous Acid; Serum Albumin, Bovine; Superoxide Dismutase; Synucleins; Tyrosine | 2002 |
Inhibition of protein tyrosine/mitogen-activated protein kinase phosphatase activity is associated with D2 dopamine receptor supersensitivity in a rat model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Oxidopamine; Parkinson Disease; PC12 Cells; Phosphorylation; Protein Tyrosine Phosphatases; Quinpirole; Rats; Receptors, Dopamine D2; Sympatholytics; Tyrosine; Vanadates | 2002 |
Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Behavior, Animal; Benzylamines; Catalepsy; Disease Models, Animal; Dopamine; Dopamine Antagonists; Drug Interactions; Haloperidol; Hippocampus; Homovanillic Acid; Hypothalamus; Locus Coeruleus; Male; Medial Forebrain Bundle; Nerve Degeneration; Neurotoxins; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Reaction Time; Serotonin; Substantia Nigra; Thalamus; Tyrosine | 2003 |
Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons.
Topics: Animals; Antioxidants; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Carrier Proteins; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Death; Cell Line; Cell Survival; Cells, Cultured; Chelating Agents; Dopamine; Enzyme Activation; Enzyme Inhibitors; Genes, Dominant; Imidazoles; Immunoblotting; Immunohistochemistry; Mice; Mitochondria; Mitogen-Activated Protein Kinases; Neurons; Nitric Oxide; Oxidative Stress; Oxidopamine; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Reactive Oxygen Species; Superoxide Dismutase; Time Factors; Tyrosine | 2004 |
Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Basal Ganglia; Behavior, Animal; Benzylamines; Brain Chemistry; Catalepsy; Disease Models, Animal; Dopamine; Dopamine Agents; Homovanillic Acid; Levodopa; Locus Coeruleus; Male; Motor Activity; Norepinephrine; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Serotonin; Statistics, Nonparametric; Tyrosine | 2004 |
Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway.
Topics: Annexin A5; Apoptosis; Blotting, Western; Calcium; Cell Line, Tumor; Cell Survival; Coloring Agents; Dose-Response Relationship, Drug; Flavonoids; Flow Cytometry; Free Radicals; Guanosine Triphosphate; Humans; Membrane Potentials; Mitochondria; Models, Biological; Neurons; Nitric Oxide; Oxidopamine; Oxygen; Parkinson Disease; Phenols; Polyphenols; Quinones; Reactive Oxygen Species; Tea; Tetrazolium Salts; Thiazoles; Time Factors; Tyrosine | 2005 |
Serofendic acid prevents 6-hydroxydopamine-induced nigral neurodegeneration and drug-induced rotational asymmetry in hemi-parkinsonian rats.
Topics: Adrenergic Agents; Aldehydes; alpha-Synuclein; Animals; Behavior, Animal; Blotting, Western; CD11b Antigen; Cell Count; Cell Line; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Functional Laterality; Glial Fibrillary Acidic Protein; Humans; Immunohistochemistry; Male; Neurodegenerative Diseases; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Parkinsonian Disorders; Rats; Rats, Wistar; Reactive Oxygen Species; Rotarod Performance Test; Rotation; Substantia Nigra; Synaptophysin; Time Factors; Tyrosine; Tyrosine 3-Monooxygenase | 2005 |
(-)-Epigallocatechin-3-Gallate protects SH-SY5Y cells against 6-OHDA-induced cell death through STAT3 activation.
Topics: Adrenergic Agents; Analysis of Variance; Catechin; Cell Death; Cell Differentiation; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Interactions; Humans; Neuroblastoma; Neuroprotective Agents; Oxidopamine; STAT3 Transcription Factor; Tetrazolium Salts; Thiazoles; Thymidine; Time Factors; Tritium; Tyrosine | 2009 |
PET imaging in rats to discern temporal onset differences between 6-hydroxydopamine and tau gene vector neurodegeneration models.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Fluorine Radioisotopes; Genetic Vectors; Male; Nerve Degeneration; Neurotoxins; Oxidopamine; Parkinsonian Disorders; Positron-Emission Tomography; Predictive Value of Tests; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sympatholytics; tau Proteins; Time Factors; Transfection; Tyrosine | 2009 |
Protective effect of tetrahydroxystilbene glucoside on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway.
Topics: Animals; Apoptosis; Cell Nucleus; Cell Survival; Gene Expression Regulation, Enzymologic; Glucosides; Intracellular Space; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Oxidopamine; PC12 Cells; Rats; Reactive Oxygen Species; Signal Transduction; Stilbenes; Tyrosine | 2011 |
Microwave-assisted synthesis of hydroxyphenyl nitrones with protective action against oxidative stress.
Topics: Anti-Inflammatory Agents; Antioxidants; Blood-Brain Barrier; Cell Survival; Dose-Response Relationship, Drug; Humans; Microwaves; Molecular Structure; Neuroblastoma; Neuroprotective Agents; Nitrogen Oxides; Oxidative Stress; Oxidopamine; Peroxynitrous Acid; Structure-Activity Relationship; Tyrosine | 2012 |
Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's Disease.
Topics: Animals; Cell Fractionation; Cells, Cultured; Cytokines; Disease Models, Animal; Encephalitis; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Nitric Oxide; Oxidopamine; Parkinson Disease; Phosphorylation; Protein Kinase C-delta; Proto-Oncogene Proteins c-fyn; Tumor Necrosis Factor-alpha; Tyrosine; Tyrosine 3-Monooxygenase | 2015 |
L-DOPA Reverses the Increased Free Amino Acids Tissue Levels Induced by Dopamine Depletion and Rises GABA and Tyrosine in the Striatum.
Topics: Amino Acids; Animals; Aspartic Acid; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Forelimb; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Levodopa; Mice; Oxidopamine; Rotarod Performance Test; Taurine; Tyrosine | 2016 |
Comparative assessment of 6-[
Topics: Animals; Apomorphine; Aromatic-L-Amino-Acid Decarboxylases; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Fluorine Radioisotopes; Image Processing, Computer-Assisted; Male; Neostriatum; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Presynaptic; Stereotyped Behavior; Tyrosine | 2017 |